PacificHealth Laboratories Inc
PacificHealth Laboratories, Inc. engages in the development of nutritional products that enhance health and athletic performance in the United States and internationally. It primarily focuses on sports performance, hydration, fueling, and muscle recovery. The company provides ENDUROX R4, a muscle recovery drink; ACCELERADE protein powered sports drink; ACCEL GEL, a energy gel; Body Glove Surge; E… Read more
PacificHealth Laboratories Inc (PHLI) - Net Assets
Latest net assets as of September 2012: $827.13K USD
Based on the latest financial reports, PacificHealth Laboratories Inc (PHLI) has net assets worth $827.13K USD as of September 2012.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.99 Million) and total liabilities ($1.17 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $827.13K |
| % of Total Assets | 41.52% |
| Annual Growth Rate | -6.73% |
| 5-Year Change | -66.66% |
| 10-Year Change | -45.8% |
| Growth Volatility | 163.62 |
PacificHealth Laboratories Inc - Net Assets Trend (1996–2011)
This chart illustrates how PacificHealth Laboratories Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for PacificHealth Laboratories Inc (1996–2011)
The table below shows the annual net assets of PacificHealth Laboratories Inc from 1996 to 2011.
| Year | Net Assets | Change |
|---|---|---|
| 2011-12-31 | $1.23 Million | +121.46% |
| 2010-12-31 | $555.72K | -53.05% |
| 2009-12-31 | $1.18 Million | -50.88% |
| 2008-12-31 | $2.41 Million | -34.72% |
| 2007-12-31 | $3.69 Million | -6.76% |
| 2006-12-31 | $3.96 Million | +591.13% |
| 2005-12-31 | $572.88K | +131.60% |
| 2004-12-31 | $247.36K | -91.09% |
| 2003-12-31 | $2.78 Million | +22.33% |
| 2002-12-31 | $2.27 Million | -51.44% |
| 2001-12-31 | $4.68 Million | +163.85% |
| 2000-12-31 | $1.77 Million | -29.12% |
| 1999-12-31 | $2.50 Million | -32.43% |
| 1998-12-31 | $3.70 Million | -40.32% |
| 1997-12-31 | $6.20 Million | +77.14% |
| 1996-12-31 | $3.50 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to PacificHealth Laboratories Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1993477300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2011)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $52.18K | 4.24% |
| Other Components | $21.31 Million | 1731.77% |
| Total Equity | $1.23 Million | 100.00% |
PacificHealth Laboratories Inc Competitors by Market Cap
The table below lists competitors of PacificHealth Laboratories Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SheerVision Inc
PINK:SVSO
|
$0.92 |
|
China Clean Energy
PINK:CCGY
|
$0.92 |
|
Radium Resources Corp
PINK:RADR
|
$0.92 |
|
Ubiquitech Software
PINK:UBQU
|
$0.92 |
|
USCorp
PINK:USCS
|
$0.92 |
|
ComF5 International Inc
PINK:CMFV
|
$0.92 |
|
Ijj Corporation
PINK:IJJP
|
$0.92 |
|
KAL Energy Inc
PINK:KALG
|
$0.92 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in PacificHealth Laboratories Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2010 to 2011, total equity changed from 555,720 to 1,230,725, a change of 675,005 (121.5%).
- Net loss of 486,311 reduced equity.
- Share repurchases of 1,095,000 reduced equity.
- Other factors increased equity by 2,256,316.
Equity Change Factors (2010 to 2011)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-486.31K | -39.51% |
| Share Repurchases | $1.09 Million | -88.97% |
| Other Changes | $2.26 Million | +183.33% |
| Total Change | $- | 121.46% |
Book Value vs Market Value Analysis
This analysis compares PacificHealth Laboratories Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1996-12-31 | $1.40 | $0.00 | x |
| 1997-12-31 | $1.32 | $0.00 | x |
| 1998-12-31 | $0.78 | $0.00 | x |
| 1999-12-31 | $0.54 | $0.00 | x |
| 2000-12-31 | $0.39 | $0.00 | x |
| 2001-12-31 | $0.72 | $0.00 | x |
| 2002-12-31 | $0.37 | $0.00 | x |
| 2003-12-31 | $0.39 | $0.00 | x |
| 2004-12-31 | $0.02 | $0.00 | x |
| 2005-12-31 | $0.06 | $0.00 | x |
| 2006-12-31 | $0.30 | $0.00 | x |
| 2007-12-31 | $0.28 | $0.00 | x |
| 2008-12-31 | $0.18 | $0.00 | x |
| 2009-12-31 | $0.08 | $0.00 | x |
| 2010-12-31 | $0.03 | $0.00 | x |
| 2011-12-31 | $0.06 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently PacificHealth Laboratories Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -39.51%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -7.03%
- • Asset Turnover: 3.66x
- • Equity Multiplier: 1.54x
- Recent ROE (-39.51%) is above the historical average (-118.97%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1996 | 2.86% | 3.23% | 0.74x | 1.20x | $-250.00K |
| 1997 | -69.35% | -126.47% | 0.47x | 1.16x | $-4.92 Million |
| 1998 | -67.57% | -250.00% | 0.23x | 1.19x | $-2.87 Million |
| 1999 | -48.00% | -57.14% | 0.75x | 1.12x | $-1.45 Million |
| 2000 | -54.04% | -24.93% | 1.50x | 1.44x | $-1.13 Million |
| 2001 | 6.11% | 4.65% | 1.23x | 1.07x | $-181.90K |
| 2002 | -113.21% | -50.20% | 1.89x | 1.20x | $-2.80 Million |
| 2003 | -52.25% | -26.61% | 1.50x | 1.30x | $-1.73 Million |
| 2004 | -1019.20% | -37.04% | 2.64x | 10.42x | $-2.55 Million |
| 2005 | -110.68% | -11.65% | 1.75x | 5.44x | $-691.36K |
| 2006 | 57.31% | 36.54% | 1.19x | 1.32x | $1.87 Million |
| 2007 | -34.56% | -17.18% | 1.57x | 1.28x | $-1.65 Million |
| 2008 | -82.76% | -27.56% | 2.15x | 1.40x | $-2.24 Million |
| 2009 | -141.61% | -20.96% | 3.14x | 2.15x | $-1.79 Million |
| 2010 | -137.02% | -10.57% | 5.05x | 2.56x | $-816.99K |
| 2011 | -39.51% | -7.03% | 3.66x | 1.54x | $-609.38K |
Industry Comparison
This section compares PacificHealth Laboratories Inc's net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $1,833,853,398
- Average return on equity (ROE) among peers: 27.58%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| PacificHealth Laboratories Inc (PHLI) | $827.13K | 2.86% | 1.41x | $0.92 |
| Acme United Corporation (ACU) | $19.90 Million | 2.51% | 0.55x | $132.86 Million |
| Beiersdorf Aktiengesellschaft (BDRFF) | $3.02 Billion | 8.59% | 0.75x | $11.93 Billion |
| Science to Consumers Inc (BEUT) | $-3.05K | 0.00% | 0.00x | $1.09K |
| Société BIC SA (BICEY) | $1.70 Billion | 16.88% | 0.41x | $566.61 Million |
| Blue Moon Group Holdings Limited (BLUMY) | $12.35 Billion | 8.22% | 0.18x | $1.01 Billion |
| Bemax Inc (BMXC) | $-244.86K | 0.00% | 0.00x | $3.63K |
| Bruush Oral Care Inc. (BRSHF) | $-216.93K | 0.00% | 0.00x | $335.48 |
| Park Ha Biological Technology Co., Ltd. (BYAH) | $-578.18K | 0.00% | 0.00x | $11.97 Million |
| Church & Dwight Company Inc (CHD) | $284.43 Million | 16.52% | 2.34x | $22.97 Billion |
| Colgate-Palmolive Company (CL) | $971.00 Million | 223.07% | 14.49x | $67.85 Billion |